Allergan, Inc. (NYSE:AGN)

CAPS Rating: 4 out of 5

A technology-driven, global health care company which discovers, develops and commercializes pharmaceutical and medical device products for markets such as ophthalmic, neurological, medical aesthetics, medical dermatological etc.

Recs

0
Player Avatar JoyofMoney (71.17) Submitted: 7/9/2008 2:32:51 AM : Outperform Start Price: $51.69 AGN Score: +69.00

Terrible P/E ratios but the rest of the fundamentals were good enough to sell me. Medical devices, a complement to pharmaceutical as well as a specialty pharmaceutical niche. Had narrow movement in stock price in the past few weeks and I liked the price being toward its 52 week low. Optimistically, I am looking for strength out of this one in a market that is volatile.

Featured Broker Partners


Advertisement